Eden Research plc

November 12, 2010 05:32 ET

Granting of encapsulation technology patent

                                                                                      12 November 2010

                                           EDEN RESEARCH PLC
                                         ("Eden" or "Company")

                              Granting of encapsulation technology patent

Eden  Research plc, a leading UK agrochemical development company, is pleased to announce the granting
of  its platform encapsulation technology patent in New Zealand and Mexico. The patent is also  in  an
advanced state of registration in a number of other countries.

Eden's strategy is focused on the development and commercialisation of its terpene-based encapsulation
technology for agricultural and non-agricultural uses.

Terpenes  are  natural  compounds which function as defence mechanisms in many plant  groups  and  are
released in response to infection, attack by pests, stress or mechanical injury. Terpenes are  already
widely used in the food flavouring, cosmetic and pharmaceutical industries.

Historically,  terpenes  have  had  limited commercial use in the agrochemical  sector  due  to  their
volatility,  phytotoxicity and poor solubility. Eden's platform encapsulation technology provides  the
unique,  natural  solution to these problems and enables terpenes to be used  as  effective,  low-risk

Clive  Newitt, Managing Director of Eden Research plc said, "These patent grants further validate  our
terpene-based  platform technology and underlines the significant value of our  intellectual  property
portfolio.  Given that New Zealand has a well established wine market, this is clearly good  news  for
our  licensing partners who will be selling their pesticidal products, using our technology,  in  this
territory. Mexico is also important for us and, in particular, our partner, Stockton Agrimor AG, given
the  agreement  we  recently entered into with them for our nematode product  for  Latin  America  and

The Directors of Eden are responsible for the contents of this announcement.


Eden Research plc                                                        01993 862761
Clive Newitt, Managing Director

St Helens Capital Partners LLP                                           020 7368 6959
Mark Anwyl

Contact Information

  • Eden Research plc